Abstract
Machado-Joseph disease (MJD) is an autosomal dominant neurodegenerative disorder that is clinically characterized by cerebellar ataxia and various associated symptoms. The disease is caused by an unstable expansion of the CAG repeat in the MJD gene. This gene is mapped to chromosome 14q32.1. To determine its genomic structure, we constructed a contig composed of six cosmid clones and eight bacterial artificial chromosome (BAC) clones. It spans approximately 300 kb and includes MJD. We also determined the complete sequence (175,330 bp) of B445M7, a human BAC clone that contains MJD. The MJD gene was found to span 48,240 bp and to contain 11 exons. Northern blot analysis showed that MJD mRNA is ubiquitously expressed in human tissues, and in at least four different sizes; namely, 1.4, 1.8, 4.5, and 7.5 kb. These different mRNA species probably result from differential splicing and polyadenylation, as shown by sequences of the 21 independent cDNA clones isolated after the screening of four human cDNA libraries prepared from whole brain, caudate, retina, and testis. The sequences of these latter clones relative to the MJD gene in B445M7 indicate that there are three alternative splicing sites and eight polyadenylation signals in MJD that are used to generate the differently sized transcripts.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Received: March 7, 2001 / Accepted: April 17, 2001
Rights and permissions
About this article
Cite this article
Ichikawa, Y., Goto, J., Hattori, M. et al. The genomic structure and expression of MJD, the Machado-Joseph disease gene. J Hum Genet 46, 413–422 (2001). https://doi.org/10.1007/s100380170060
Issue Date:
DOI: https://doi.org/10.1007/s100380170060
This article is cited by
-
Machado Joseph-Disease Is Rare in the Peruvian Population
The Cerebellum (2022)
-
Genetic Variation in ATXN3 (Ataxin-3) 3′UTR: Insights into the Downstream Regulatory Elements of the Causative Gene of Machado-Joseph Disease/Spinocerebellar Ataxia Type 3
The Cerebellum (2022)
-
Toward RNAi Therapy for the Polyglutamine Disease Machado–Joseph Disease
Molecular Therapy (2013)
-
Sequence Analysis of 5′ Regulatory Regions of the Machado–Joseph Disease Gene (ATXN3)
The Cerebellum (2012)
-
Machado-Joseph Disease: from first descriptions to new perspectives
Orphanet Journal of Rare Diseases (2011)